Co-Diagnostics, Inc. (CODX) NASDAQ

6.69

+0.4899(+7.90%)

Updated at June 02 12:44PM

Currency In USD

Co-Diagnostics, Inc.

Address

2401 S. Foothill Dr.

Salt Lake City, UT 84109

United States of America (the)

Phone

801 438 1036

Website

https://co-dx.com

Sector

Healthcare

Industry

Medical - Devices

Employees

132

First IPO Date

July 12, 2017

Key Executives

Name	Title	Pay	Year Born
Dwight H. Egan	Chairman, CEO & President	460,000	1953
Richard David Abbott	President	305,000	1972
Brian L. Brown	Chief Financial Officer & Company Secretary	365,000	1976
Christopher Thurston	Chief Technology Officer	0	N/A
Mayuranki Almaula	Senior Vice President of Overseas Operations & Strategic Alliances	0	N/A
Dan Bohrer	Vice President of Finance & Accounting	0	N/A
David Nielsen	Chief Operating Officer	0	N/A
Seth Egan	Chief Commercialization Officer	0	N/A
Andrew Benson	Head of Investor Relations	0	N/A

Description

Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction testing to patients in point-of-care and at-home setting. It also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus, malaria, chikungunya, dengue, and the zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. The company was incorporated in 2013 and is based in Salt Lake City, Utah.